Disclosure of interest: All authors have nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P153 - ESOC25-601 MIDDLE MENINGEAL ARTERY EMBOLIZATION IN A COHORT OF PATIENTS ON ANTITHROMBOTIC THERAPY Eduardo Fandio 1 , Isabel Bermudez-Coronel 1 , Mara Prez 1 , Jose Carlos Mendez 1 , Rodrigo Carrasco 1 , Vctor Rodrguez 1 , Lara Castellanos 1 , Eva Cortina 1 , Karolina Monsior 1 , Luis Ley 1 1 Hospital Universitario Ramn y Cajal, Madrid, Spain Background and Aims: To evaluate the effectiveness and safety of middle meningeal artery embolization in chronic subdural hematoma patients on antithrombotic therapy
Anecdotal reports suggest tolerance over extended periods, but unknown risks remain
This causes the rate of the GS reaction to come back down to normal despite the upregulation of CBS and GCS and cause the steady concentrations of cytosolic GSH and the blood concentrations of GSH and cysteine to decline below normal
Comme l'habitude, la mission s'est termine Lom avec une rencontre-tat des lieux entre SSD et les autorits sanitaires du pays
I hope the NHS Constitution will help you to do this
Concentration: 5.000 mg/mL (5000 mcg/mL) How much of the Peptide do you want in each dose
